A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cynthia Sirard
Leap Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Honorhealth
Scottsdale, Arizona, United States
- Florida Cancer Specialists & Research Institute
West Palm Beach, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Hca Midwest Health System Clinical Research
Kansas City, Missouri, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ohio State University Wexner Medical Center
Hilliard, Ohio, United States
- Stephenson Cancer Center - University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- the University of Tennessee West Cancer Center
Germantown, Tennessee, United States
- Tennessee Oncology, Pllc
Nashville, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Virginia Cancer Center
Charlottesville, Virginia, United States
- University of Wisconsin
Madison, Wisconsin, United States
- Froedtert and Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Mar 2018
- Primary completion
- 9 Sept 2020
- Completion
- 27 Jan 2021
- Last update posted
- 1 Aug 2025
- Registered enrollment
- 111
- Registry id
- NCT03395080
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.